Callan Family Office’s Zimmer Biomet ZBH Stock Holding History

Callan Family Office’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.21M	Buy	68,650 +17,622	+35%	+$1.62M	0.14%	157
2025 Q4	$4.59M	Sell	51,028 -7,166	-12%	-$679K	0.1%	203
2025 Q3	$5.73M	Buy	58,194 +3,972	+7%	+$394K	0.18%	127
2025 Q2	$4.95M	Buy	54,222 +36,059	+199%	+$3.49M	0.16%	152
2025 Q1	$2.06M	Buy	18,163 +7,252	+66%	+$776K	0.15%	125
2024 Q4	$1.15M	Buy	+10,911	New	+$1.17M	0.07%	223

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Callan Family Office's ZBH Position: Q1 2026 in Review

Callan Family Office increased its Zimmer Biomet (ZBH) stake by 35% in Q1 2026, buying an estimated $1.62M and bringing the position to 68,650 shares worth $6.21M. The position accounts for 0.14% of the portfolio, ranked #157.

Callan Family Office first reported a position in ZBH in Q4 2024 and has held it in 6 quarters since. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Callan Family Office held 68,650 shares of Zimmer Biomet worth $6.21M as of Q1 2026.
Callan Family Office bought 17,622 Zimmer Biomet shares in Q1 2026, an estimated $1.62M.
Zimmer Biomet made up 0.14% of Callan Family Office's portfolio in Q1 2026, its #157 holding.
Callan Family Office first reported a position in Zimmer Biomet in Q4 2024 and has held it in 6 quarters since.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.